Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Re Joint Venture

12 Aug 2009 09:24

RNS Number : 3017X
Compagnie de Saint-Gobain
12 August 2009
 



August 12, 2009

Saint-Gobain steps up its growth in renewable energy with an increased participation in Avancis

As part of its development strategy for solar energy, Saint-Gobain is acquiring Shell's share of Avancis, a joint venture between the two companies. 

Avancis has developed highly competitive technology for thin-film CIS (Copper, Indium and Selenide) to manufacture photovoltaic modules. With an annual capacity of 20 megawatts, the company's first plant is already operating in TorgauGermany. This extremely promising technology necessitates expertise in glass coating and in glass thermal treatment, two processes belonging to the core portfolio of Saint-Gobain, a worldwide leader in flat glass for the building and automotive industries.

Saint-Gobain intends to accelerate the industrial development of Avancis.

Saint-Gobain provides a vast range of products and services in solar energy via Saint-Gobain Solar, its new entity which groups all of Saint-Gobain's solar businesses. Present across the whole value chain, Saint-Gobain Solar's strategy hinges on three independent activities: 

The making and selling of high-tech components for PV modules (special glass, performance plastics, etc.) and high-performance mirrors for solar thermal plant operators.

The production by its Avancis company of thin-film PV modules using CIS (Copper, Indium, Selenide) technology, for distributors and integrators.

The design and marketing of PV solutions for residential homes, offices, industrial installations and farm buildings.

Analyst & Investor Relations

Press Relations

Florence Triou-Teixeira +33 1 47 62 45 19

Etienne Humbert +33 1 47 62 30 49

Vivien Dardel  +33 1 47 62 44 29

Sophie Chevallon +33 1 47 62 30 48

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
JVEVLLBFKVBLBBX
Date   Source Headline
18th May 20068:17 amRNSIssue of Debt
27th Apr 20065:14 pmRNS1st Quarter Results
27th Apr 20065:09 pmRNSDisposal
27th Mar 20066:30 pmRNSPublication of Prospectus
24th Mar 20069:25 amRNSFinal Results
2nd Feb 20068:22 amRNSFinal Results
8th Dec 20051:08 pmRNSCompulsory Acqn of Shares
17th Nov 20057:02 amRNSOffer for BPB plc
14th Nov 20057:30 amRNSOffer Update
9th Nov 20053:29 pmRNSOffer Update
31st Oct 20057:36 amRNSOffer Update
26th Oct 20054:59 pmRNSAcquisition
25th Oct 20055:24 pmRNS3rd Quarter Results
5th Oct 20055:08 pmRNSResponse to BPB's statement
5th Oct 20058:10 amRNS600m return, dividends up
5th Oct 20057:58 amRNSBPB: Offer Timetable Extended
3rd Oct 200510:12 amRNSLow level of acceptances
3rd Oct 20057:30 amRNSOffer Update
20th Sep 20055:13 pmRNSAcquisition
15th Sep 20052:14 pmRNSResponse to Saint-Gobain
14th Sep 20054:00 pmRNSResponse to BPB Document
31st Aug 20059:28 amRNSResponse to St Gobain offer
31st Aug 20058:35 amRNSOffer Document Posted
3rd Aug 20051:04 pmRNSResponse to St-Gobain offer
3rd Aug 200512:13 pmRNSOffer for BPB PLC
3rd Aug 20057:20 amRNSRejects unsolicited proposal
29th Jul 20057:02 amRNSInterim Results
29th Jul 20057:01 amRNSInterim Results
22nd Jul 20055:00 pmRNSResponse to BPB plc Statement
22nd Jul 200512:34 pmRNSStmnt re BPB PLC - Addendum
21st Jul 20052:22 pmRNSStatement re BPB PLC
30th Jun 20055:05 pmRNSDisposal
21st Jun 20057:51 amRNSAcquisition
9th Jun 20056:13 pmRNSAGM Statement
26th May 20058:11 amRNSDisposal
4th May 20055:12 pmRNSAppointments
4th May 20058:02 amRNSAppointment
4th May 20057:55 amRNSAcquisition
26th Apr 20056:00 pmRNS1st Quarter Results
19th Apr 20059:34 amRNSRe Joint Venture
7th Apr 20057:46 amRNSAcquisition
24th Mar 20056:35 pmRNSFinal Results
24th Feb 20059:34 amRNSStatement re Investigation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.